The pharmaceutical markets in Eurasia are on the rise, with retail leading the charge, accounting for 58% of total sales. Rx products dominate, making up 60-70% of all sales and underscoring their vital importance in the region. 

Get the latest insights on the performance of Kazakhstan, Uzbekistan, Belarus, Armenia, Azerbaijan, Georgia, Moldova, and Mongolia in the first half of 2024 in IQVIA’s comprehensive report.

Stay ahead of the curve! The Eurasian Pharmaceutical Summit that will take place in Tashkent and online on the 17th – 19th September will spotlight development trends across Central Asia, the Caucasus, and Eastern Europe. This is your final opportunity to join the region’s top pharmaceutical conference!